Drug Type Small molecule drug |
Synonyms Nipradilol (JAN/INN), K-351, KT-210 + [3] |
Target |
Mechanism β-adrenoceptors antagonists(Beta adrenergic receptors antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date JP (20 Sep 1988), |
Regulation- |
Molecular FormulaC15H22N2O6 |
InChIKeyOMCPLEZZPVJJIS-UHFFFAOYSA-N |
CAS Registry81486-22-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01691 | Nipradilol | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Glaucoma | JP | 16 Jun 1996 | |
Ocular Hypertension | JP | 16 Jun 1996 | |
Angina Pectoris | JP | 20 Sep 1988 | |
Hypertension | JP | 20 Sep 1988 |
Not Applicable | - | 8 | rekboterro(cnziqucmtq) = pxelvktreg wnjphmhoeg (ixvywiyheu ) View more | - | 01 Apr 2011 | ||
Not Applicable | - | Nipradilol-treated eyes | kdjrjdthws(toldecfxax) = fiixfmvyih iokjjgibba (wiuwftwcnj ) | - | 01 May 2004 | ||
topical nipradilol | kdjrjdthws(toldecfxax) = pgcjdbvosr iokjjgibba (wiuwftwcnj ) | ||||||
Not Applicable | - | - | mddghxgtkg(zystkmmbsj) = fvrvaeqica nprothtevx (yhkgodmvxt ) | Positive | 01 Dec 2002 | ||
mddghxgtkg(zystkmmbsj) = banzhkfxuu nprothtevx (yhkgodmvxt ) |